These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33272174)

  • 21. Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems.
    Patel V; Chavda V; Shah J
    Curr Neuropharmacol; 2021; 19(5):693-710. PubMed ID: 32851949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery aspects of antioxidants in diabetes management.
    Duvvuri LS; Katiyar S; Kumar A; Khan W
    Expert Opin Drug Deliv; 2015 May; 12(5):827-44. PubMed ID: 25582375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress.
    Harwansh RK; Mukherjee PK; Bahadur S; Biswas R
    Life Sci; 2015 Nov; 141():202-11. PubMed ID: 26437269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of Nano and Bulk Monoisoamyl DMSA against arsenic-induced neurotoxicity in rats.
    Naqvi S; Kumar P; Flora SJS
    Biomed Pharmacother; 2020 Dec; 132():110871. PubMed ID: 33069968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
    J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.
    Brenza TM; Ghaisas S; Ramirez JEV; Harischandra D; Anantharam V; Kalyanaraman B; Kanthasamy AG; Narasimhan B
    Nanomedicine; 2017 Apr; 13(3):809-820. PubMed ID: 27771430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease.
    Akel H; Ismail R; Csóka I
    Eur J Pharm Biopharm; 2020 Mar; 148():38-53. PubMed ID: 31926222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers.
    Devi PU; Manocha A; Vohora D
    Expert Opin Pharmacother; 2008 Dec; 9(18):3169-77. PubMed ID: 19040338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant treatment in Alzheimer's disease: current state.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiopental sodium loaded solid lipid nano-particles attenuates obesity-induced cardiac dysfunction and cardiac hypertrophy via inactivation of inflammatory pathway.
    Zhu C; Li W; Wang X; Xue J; Zhao L; Song Y; Zhou T; Zhang M
    Drug Deliv; 2020 Dec; 27(1):1188-1200. PubMed ID: 32762480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoencapsulation of carotenoids within lipid-based nanocarriers.
    Rostamabadi H; Falsafi SR; Jafari SM
    J Control Release; 2019 Mar; 298():38-67. PubMed ID: 30738975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress.
    Yamada Y; Takano Y; Satrialdi ; Abe J; Hibino M; Harashima H
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31948035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of nanocarrier-based CNS delivery systems.
    Tiwari SB; Amiji MM
    Curr Drug Deliv; 2006 Apr; 3(2):219-32. PubMed ID: 16611008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tributyltin induces oxidative damage, inflammation and apoptosis via disturbance in blood-brain barrier and metal homeostasis in cerebral cortex of rat brain: an in vivo and in vitro study.
    Mitra S; Gera R; Siddiqui WA; Khandelwal S
    Toxicology; 2013 Aug; 310():39-52. PubMed ID: 23743147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S; Karagiannis TC
    Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sivelestat-loaded nanostructured lipid carriers modulate oxidative and inflammatory stress in human dental pulp and mesenchymal stem cells subjected to oxygen-glucose deprivation.
    Prakash R; Mishra RK; Ahmad A; Khan MA; Khan R; Raza SS
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111700. PubMed ID: 33545859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Characterization of Nasal Delivery of Selegiline Hydrochloride Loaded Nanolipid Carriers for the Management of Parkinson's Disease.
    Mishra N; Sharma S; Deshmukh R; Kumar A; Sharma R
    Cent Nerv Syst Agents Med Chem; 2019; 19(1):46-56. PubMed ID: 30474538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antioxidants: scope, limitations and relevance of assays.
    Pinchuk I; Shoval H; Dotan Y; Lichtenberg D
    Chem Phys Lipids; 2012 Sep; 165(6):638-47. PubMed ID: 22721987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.